Kuntal Joshi
Plus aucun poste en cours
Profil
Kuntal Joshi worked as a Marketing Director at Nidek Co., Ltd.
and as the President-Asia Pacific Region at AEON Biopharma Sub, Inc. He obtained an undergraduate degree from Rutgers State University of New Jersey and an MBA from Fairleigh Dickinson University.
Anciens postes connus de Kuntal Joshi
| Sociétés | Poste | Fin |
|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Corporate Officer/Principal | - |
Nidek Co., Ltd.
 Nidek Co., Ltd. Medical DistributorsDistribution Services Nidek Co. Ltd. develops ophthalmic surgical and diagnostic equipment for the optical and eye care industries. It offers ophthalmic surgical devices, examination and diagnostic devices, electronic medical record and practice management medical filing systems, intra-ocular lenses and dermatological surgical lasers. The company was founded by Hideo Ozawa in July 1971 and is headquartered in Gamagori, Japan. | Sales & Marketing | - |
Formation de Kuntal Joshi
| Rutgers State University of New Jersey | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nidek Co., Ltd.
Nidek Co., Ltd. Medical DistributorsDistribution Services Nidek Co. Ltd. develops ophthalmic surgical and diagnostic equipment for the optical and eye care industries. It offers ophthalmic surgical devices, examination and diagnostic devices, electronic medical record and practice management medical filing systems, intra-ocular lenses and dermatological surgical lasers. The company was founded by Hideo Ozawa in July 1971 and is headquartered in Gamagori, Japan. | Distribution Services |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |